[Remote] Clinical Research Lead - Immunology, Neurodegeneration, Cardiometabolic Health, Investigator Engagement at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

Clinical trial executionInvestigator engagementSite performance managementTherapeutic knowledgeScientific knowledgeEnrollment strategiesRelationship buildingClinical DevelopmentMedical AffairsRegulatory affairs

Questions & Answers

Common questions about this position

Is this a remote position or does it require field work?

This is a field-based role focused on investigator engagement and site performance management.

What are the primary responsibilities of the Clinical Research Lead?

The role involves managing clinical investigators from identification through study closeout, building strategic relationships, influencing enrollment strategies, leading site-level trial management, and capturing site insights to optimize studies.

What skills or expertise are needed for this position?

Candidates need deep therapeutic and scientific knowledge, strategic agility, strong relationship-building skills, and expertise in clinical trial management including protocol understanding, enrollment strategies, and performance metrics.

What is the employment type for this role?

This is a full-time position.

What makes a strong candidate for the Clinical Research Lead role?

A strong candidate will have experience as a scientific leader in clinical trials, proven ability to build high-trust investigator relationships, and skills in driving enrollment and site performance with strategic insight.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free